Overview
Vista Pharmaceuticals Limited formulates pharmaceutical products, primarily in therapeutic areas like gastrointestinal, pain management, and anti-infection drugs, targeting common ailments.
The company was the first Indian firm to receive USFDA approval for producing both OTC and prescription drugs for the US market in 1994.
Vista Pharmaceuticals has set up a 100% EOU to manufacture drug formulations with a significant annual capacity, showing its commitment to scaling operations.
The company's Indian facility received USFDA approval in 2010 for producing ANDA products, reinforcing its quality compliance and operational standards.
Vista Pharmaceuticals has an established marketing and distribution network in the United States, ensuring strong international presence and demand.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
46 Cr
- Volatility
Low Risk
- P/E Ratio
0.0
- Industry P/E
34.1
- PEG Ratio
—
- P/B Ratio
1.3
- 52W High
11.87
- 52W Low
5.71
Financial Ratios
Sales CAGR
- 1Y
- -2.14%
- 3Y
- 194.46%
- 5Y
- -15.04%
- 10Y
- -4.59%
Profit CAGR
- 1Y
- -3.10%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- -33.10%
- 3Y
- -12.09%
- 5Y
- -9.28%
- 10Y
- -5.14%
ROCE
- TTM
- -32.42%
- 3Y
- -9.71%
- 5Y
- -7.77%
- 10Y
- -2.24%
Technicals
Oscillators
Neutral
Bearish
3
Neutral
6
Bullish
5
Overall
Bearish
Bearish
24
Neutral
6
Bullish
16
Moving Averages
Bearish
Bearish
21
Neutral
0
Bullish
11
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
